Abstract:Many aggregation-induced emission luminogens (AIEgens) not only act as photosensitizers to generate cytotoxic reactive oxygen species under the irradiation of appropriate light, but also emit bright fluorescence for positioning and tracking, realizing image-guided photodynamic therapy. However, few AIEgens can achieve long-term near-infrared bioimaging, and the design of AIEgens rarely involves multi-faceted functional optimization and the combined use of different AIE groups. In this study, a series of low-toxic salicylaldehyde-based Schiff base AIEgens (NPy-AIE, NNPy-AIE, TPy-AIE and TTPy-AIE) are rational designed from multiple aspects to study structure-function relationships, which all exhibit excellent long-term bioimaging capability. Starting from NPy-AIE, its water solubility is enhanced by increasing the number of cations and constructing hydrophilic groups to obtain NNPy-AIE. Dimethylaniline groups of NPy-AIE are replaced with triphenylamine groups to acquire TPy-AIE with enhanced AIE activity. Thiophene groups are introduced in TPy-AIE to obtain TTPy-AIE with larger conjugation structure and electron donor-acceptor strength. The first two red-emitting AIEgens have better long-term mitochondrial targeting capability. NNPy-AIE has better water solubility and mitochondrial membrane potential detection capabilities. In particular, the latter two near-infrared emitting AIEgens can not only achieve long-term in vivo and in vitro near-infrared imaging, but also generate singlet oxygen under white light irradiation, which increases the level of intracellular reactive oxygen species and the proportion of apoptotic cells, showing potential as photosensitizers for image-guided photodynamic therapy. In vivo photodynamic therapy experiment of TTPy-AIE in 4T1 tumor-bearing mice has confirmed its excellent biocompatibility and photodynamic therapy ability.

A novel nitrogen mustard functionalized tripodal AIE compound act as prodrug for fluorescent imaging and anticancer

A Novel TMTP1-modified Theranostic Nanoplatform for Targeted in Vivo NIR-II Fluorescence Imaging-guided Chemotherapy of Cervical Cancer

Novel Mitochondria-Targeted and Fluorescent DNA Alkylation Agents with Highly Selective Activity Against Cancer Cells

A Mitochondria-targeted AIEgen Labelled with <SUP>18</SUP>F for Breast Cancer Cell Imaging and Therapy

Mitochondria Targeting and Near-Infrared Fluorescence Imaging of a Novel Heptamethine Cyanine Anticancer Agent.

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

NIR AIE luminogens for primary and metastasis tumor imaging and tracing applications

A novel highly sensitive fluorescent probe for bioimaging biothiols and its applications in distinguishing cancer cells from normal cells.

<SUP>177</SUP>Lu Radiolabelled AIE Dots for Multimodal Imaging Guided Photothermal/Radiopharmaceutical Tumor Therapy

Radiolabeled AIE Probes As Dual-modality Imaging Agents for PET/NIR-II Fluorescence-Guided Photothermal Therapy

All-in-One Molecular Aggregation-Induced Emission Theranostics: Fluorescence Image Guided and Mitochondria Targeted Chemo- and Photodynamic Cancer Cell Ablation

Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules

Novel mitochondria-targeted, nitrogen mustard-based DNA alkylation agents with near infrared fluorescence emission.

Design and Synthesis of Novel Pyrazolo[1,5-A]Pyrimidine Derivatives Bearing Nitrogen Mustard Moiety and Evaluation of Their Antitumor Activity in Vitro and in Vivo

Tuning Long-Term Mitochondrial Imaging and Photodynamic Therapy Capabilities Through Rational Design of Aggregation-Induced Emission Luminogens

Design, synthesis, cell imaging, and bioactivity assessment of novel rhodamine-pyrimidine nido- carborane derivatives as fluorescent anticancer agents

Simple Aggregation-Induced Emission-Based Multifunctional Fluorescent Dots for Cancer Therapy in Vitro

Design and Synthesis of Novel Quinazoline Nitrogen Mustard Derivatives As Potential Therapeutic Agents for Cancer.

A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer

A copper (I) complex constructed from aminourea derivatives containing triphenylamine for tumor cell imaging and chemodynamic therapy

High-Performance Near-Infrared Aggregation-Induced Emission Luminogen with Mitophagy Regulating Capability for Multimodal Cancer Theranostics